These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11778360)

  • 1. [Molecular pathogenesis of oral candidiasis (candidosis)].
    Hermann P; Berek Z; Nagy G; Kamotsay K; Rozgonyi F
    Orv Hetil; 2001 Nov; 142(47):2621-5. PubMed ID: 11778360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral candidosis--clinical challenges of a biofilm disease.
    Rautemaa R; Ramage G
    Crit Rev Microbiol; 2011 Nov; 37(4):328-36. PubMed ID: 21777047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidosis. Epidemiology, diagnosis and therapeutic management.
    Fotos PG; Hellstein JW
    Dent Clin North Am; 1992 Oct; 36(4):857-78. PubMed ID: 1397438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and cellular mechanisms that lead to Candida biofilm formation.
    ten Cate JM; Klis FM; Pereira-Cenci T; Crielaard W; de Groot PW
    J Dent Res; 2009 Feb; 88(2):105-15. PubMed ID: 19278980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing adherence of Candida spp. to host tissues and plastic surfaces.
    el-Azizi M; Khardori N
    Indian J Exp Biol; 1999 Oct; 37(10):941-51. PubMed ID: 10783751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of IgY against Candida albicans and Candida spp. Adherence and Biofilm Formation.
    Fujibayashi T; Nakamura M; Tominaga A; Satoh N; Kawarai T; Narisawa N; Shinozuka O; Watanabe H; Yamazaki T; Senpuku H
    Jpn J Infect Dis; 2009 Sep; 62(5):337-42. PubMed ID: 19762981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The importance of adhesion capacity in Candida to pathogenicity in mucosal and skin candidiasis].
    Tomsíková A; Kotál L
    Cesk Epidemiol Mikrobiol Imunol; 1990 Jun; 39(3):182-90. PubMed ID: 2144480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of interleukin-18 in the inflammatory response against oropharyngeal candidiasis.
    Tardif F; Goulet JP; Zakrazewski A; Chauvin P; Rouabhia M
    Med Sci Monit; 2004 Aug; 10(8):BR239-49. PubMed ID: 15277983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolytic enzymes as virulence factors of Candida albicans.
    Schaller M; Borelli C; Korting HC; Hube B
    Mycoses; 2005 Nov; 48(6):365-77. PubMed ID: 16262871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans.
    Claveau I; Mostefaoui Y; Rouabhia M
    Matrix Biol; 2004 Nov; 23(7):477-86. PubMed ID: 15579314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion of Candida species to epithelial surfaces.
    Douglas LJ
    Crit Rev Microbiol; 1987; 15(1):27-43. PubMed ID: 3319419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral candidiasis: pathogenesis and host defense.
    Epstein JB; Truelove EL; Izutzu KT
    Rev Infect Dis; 1984; 6(1):96-106. PubMed ID: 6369482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface hydrophobicity of Candida albicans isolated from elder patients undergoing denture-related candidosis.
    de Souza RD; Mores AU; Cavalca L; Rosa RT; Samaranayake LP; Rosa EA
    Gerodontology; 2009 Jun; 26(2):157-61. PubMed ID: 19490138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral candidosis in patients with advanced cancer.
    Davies AN; Brailsford SR; Beighton D
    Oral Oncol; 2006 Aug; 42(7):698-702. PubMed ID: 16527512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral candidosis and associated Candida species in HIV-infected Cambodians exposed to antimycotics.
    Schmidt-Westhausen AM; Bendick C; Reichart PA; Samaranayake LP
    Mycoses; 2004 Oct; 47(9-10):435-41. PubMed ID: 15504130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium.
    Jayatilake JA; Samaranayake YH; Cheung LK; Samaranayake LP
    J Oral Pathol Med; 2006 Sep; 35(8):484-91. PubMed ID: 16918600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive Candida species disease in infants and children: occurrence, risk factors, management, and innate host defense mechanisms.
    Maródi L; Johnston RB
    Curr Opin Pediatr; 2007 Dec; 19(6):693-7. PubMed ID: 18025938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fungi in the oro-intestinal tract and their scientifically founded status].
    Knoke M
    Z Arztl Fortbild Qualitatssich; 1998 Apr; 92(3):157-62. PubMed ID: 9606881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immune mechanisms for recognition and uptake of Candida species.
    Netea MG; Maródi L
    Trends Immunol; 2010 Sep; 31(9):346-53. PubMed ID: 20705510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.